Clinical trial · Interventional
Evaluation of Virtual Reality Headsets on Cancer Patients During Day Hospital Stay
Prospective Evaluation of Virtual Reality Headsets on Cancer Patients During Day Hospital Stay
NCT06814912CI-TRIAL-00085636VIRTUELcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Use of virtula reality headsets during treatment course on day hospitalized cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Survey using a questionnaire | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- virtual reality headset
- interventionNames
- Other: Survey using a questionnaire
Primary outcomes (1)
- measure
- Rate of patients with nausea reduction compared with preview treatment administration
- timeFrame
- From the first chemotherapy injection until the end of chemotherapy injection with the virtual reality headset (at the end of the third cycle; each cycle is 21 days) )
- description
- survey : improvement of nausea
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * cancer patients * chemotherapy treatment Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.